The protective effect of the PDE-4 inhibitor rolipram on intracerebral haemorrhage is associated with the cAMP/AMPK/SIRT1 pathway
Abstract Rolipram specifically inhibits phosphodiesterase (PDE) 4, thereby preventing inactivation of the intracellular second messenger cyclic adenosine monophosphate (cAMP). Rolipram has been shown to play a neuroprotective role in some central nervous system (CNS) diseases. However, the role of P...
Guardado en:
Autores principales: | Xiao-Liu Dong, Yan-Hui Wang, Jing Xu, Nan Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/470d281fdff74772bbad6c240451252d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Potent PDE4 inhibitor activates AMPK and Sirt1 to induce mitochondrial biogenesis.
por: Sung-Jun Park, et al.
Publicado: (2021) -
Pharmacophore modeling and virtual screening for the discovery of new type 4 cAMP phosphodiesterase (PDE4) inhibitors.
por: Miaomiao Niu, et al.
Publicado: (2013) -
Intracerebral haemorrhage: A rare presentation of phaeochromocytoma
por: Swati Chhikara, et al.
Publicado: (2021) -
PdeH, a high-affinity cAMP phosphodiesterase, is a key regulator of asexual and pathogenic differentiation in Magnaporthe oryzae.
por: Ravikrishna Ramanujam, et al.
Publicado: (2010) -
Identification of pyrazolopyridazinones as PDEδ inhibitors
por: Björn Papke, et al.
Publicado: (2016)